Haematologica (Sep 2017)
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
- Tamara P. Miller,
- Yimei Li,
- Marko Kavcic,
- Kelly D. Getz,
- Yuan-Shun V. Huang,
- Lillian Sung,
- Todd A. Alonzo,
- Robert Gerbing,
- Marla H. Daves,
- Terzah M. Horton,
- Michael A. Pulsipher,
- Jessica Pollard,
- Rochelle Bagatell,
- Alix E. Seif,
- Brian T. Fisher,
- Selina Luger,
- Alan S. Gamis,
- Peter C. Adamson,
- Richard Aplenc
Affiliations
- Tamara P. Miller
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, PA, USA;Department of Biomedical and Health Informatics, The Children’s Hospital of Philadelphia, PA, USA
- Yimei Li
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Center for Clinical Epidemiology and Biostatistics Departments of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- Marko Kavcic
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA
- Kelly D. Getz
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, PA, USA
- Yuan-Shun V. Huang
- Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, PA, USA
- Lillian Sung
- Department of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada
- Todd A. Alonzo
- Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA;Children’s Oncology Group, Monrovia, CA, USA
- Robert Gerbing
- Children’s Oncology Group, Monrovia, CA, USA
- Marla H. Daves
- Department of Pediatrics, Section of Hematology-Oncology, Texas Children’s Hospital, Houston, TX, USA
- Terzah M. Horton
- Department of Pediatrics, Section of Hematology-Oncology, Texas Children’s Hospital, Houston, TX, USA
- Michael A. Pulsipher
- Division of Hematology, Oncology and BMT, Children’s Hospital of Los Angeles, USC Keck School of Medicine, CA, USA
- Jessica Pollard
- Maine Children’s Cancer Program, Maine Medical Center, Scarborough, ME, USA
- Rochelle Bagatell
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Departments of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- Alix E. Seif
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Departments of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- Brian T. Fisher
- Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, PA, USA;Center for Clinical Epidemiology and Biostatistics Departments of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;Departments of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;Infectious Diseases, The Children’s Hospital of Philadelphia, PA, USA
- Selina Luger
- Hematology/Bone Marrow Transplant, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- Alan S. Gamis
- Pediatric Hematology/Oncology, Children’s Mercy Hospital, Kansas City, MO, USA
- Peter C. Adamson
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Departments of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- Richard Aplenc
- Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, PA, USA;Department of Biomedical and Health Informatics, The Children’s Hospital of Philadelphia, PA, USA;Departments of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- DOI
- https://doi.org/10.3324/haematol.2017.168815
- Journal volume & issue
-
Vol. 102,
no. 9
Abstract
No abstracts available.